[go: up one dir, main page]

ATE455102T1 - Inhibitoren von akt (proteinkinase b) - Google Patents

Inhibitoren von akt (proteinkinase b)

Info

Publication number
ATE455102T1
ATE455102T1 AT07798410T AT07798410T ATE455102T1 AT E455102 T1 ATE455102 T1 AT E455102T1 AT 07798410 T AT07798410 T AT 07798410T AT 07798410 T AT07798410 T AT 07798410T AT E455102 T1 ATE455102 T1 AT E455102T1
Authority
AT
Austria
Prior art keywords
akt
inhibitors
protein kinase
kinase
protein
Prior art date
Application number
AT07798410T
Other languages
English (en)
Inventor
Sajan Joseph
Renhua Li
Michael Myers
Aktham Aburub
Jenny Dai
Christopher Schmid
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE455102T1 publication Critical patent/ATE455102T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07798410T 2006-06-20 2007-06-12 Inhibitoren von akt (proteinkinase b) ATE455102T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80526006P 2006-06-20 2006-06-20
US88576507P 2007-01-19 2007-01-19
PCT/US2007/070945 WO2007149730A2 (en) 2006-06-20 2007-06-12 Inhibitors of akt (protein kinase b)

Publications (1)

Publication Number Publication Date
ATE455102T1 true ATE455102T1 (de) 2010-01-15

Family

ID=38834248

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07798410T ATE455102T1 (de) 2006-06-20 2007-06-12 Inhibitoren von akt (proteinkinase b)

Country Status (28)

Country Link
US (1) US7998977B2 (de)
EP (1) EP2035385B1 (de)
JP (1) JP2009541335A (de)
KR (1) KR101067551B1 (de)
AR (1) AR061240A1 (de)
AT (1) ATE455102T1 (de)
AU (1) AU2007261120A1 (de)
BR (1) BRPI0713136A2 (de)
CA (1) CA2652612A1 (de)
CL (1) CL2007001752A1 (de)
DE (1) DE602007004333D1 (de)
DK (1) DK2035385T3 (de)
DO (1) DOP2008000053A (de)
EA (1) EA015712B1 (de)
EC (1) ECSP088992A (de)
ES (1) ES2336630T3 (de)
HR (1) HRP20100147T1 (de)
IL (1) IL195005A0 (de)
MA (1) MA30757B1 (de)
MX (1) MX2008015904A (de)
NO (1) NO20090289L (de)
PE (1) PE20080338A1 (de)
PL (1) PL2035385T3 (de)
PT (1) PT2035385E (de)
SI (1) SI2035385T1 (de)
TN (1) TNSN08529A1 (de)
TW (1) TW200812970A (de)
WO (1) WO2007149730A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009146320A1 (en) 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Therapeutic methods and compounds
CA2810844C (en) 2010-09-07 2017-03-21 Dmi Acquisition Corp. Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions
PH12014500686A1 (en) 2011-10-10 2020-12-18 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
JP6203734B2 (ja) 2011-10-10 2017-09-27 アンピオ ファーマシューティカルズ,インコーポレイテッド 変形性関節疾患の治療
HK1198812A1 (en) 2011-10-28 2015-06-12 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
MX2015010937A (es) 2013-03-15 2015-10-29 Ampio Pharmaceuticals Inc Composiciones para la movilizacion, autodireccion, expansion y diferenciacion de celulas madre y metodos para usar las mismas.
AU2014293011A1 (en) 2013-07-26 2016-03-17 Race Oncology Ltd. Compositions to improve the therapeutic benefit of bisantrene
EP3183240A4 (de) 2014-08-18 2018-06-27 Ampio Pharmaceuticals, Inc. Behandlung von gelenkerkrankungen
US10123997B2 (en) * 2015-06-15 2018-11-13 Yong Liao Target for treating hepatitis B virus
HK1246669A1 (zh) 2015-06-22 2018-09-14 Ampio Pharmaceuticals, Inc. 人血清白蛋白低分子量组分在疾病治疗中的应用
WO2017156350A1 (en) 2016-03-09 2017-09-14 K-Gen, Inc. Methods of cancer treatment
CN115916350B (zh) * 2020-07-22 2024-11-05 南京正大天晴制药有限公司 Akt抑制剂的单位剂量组合物
WO2022017448A1 (zh) * 2020-07-22 2022-01-27 南京正大天晴制药有限公司 一种二氢吡啶并[2,3-d]嘧啶酮衍生物的盐及晶型

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152807A0 (en) 2000-05-30 2003-06-24 Peptor Ltd Protein kinase inhibitors
EP1611105A1 (de) 2003-03-28 2006-01-04 Eli Lilly And Company Isochinolin-5-sulfonsäureamide als inhibitoren von akt (proteinkinase b)
GB0317315D0 (en) 2003-07-24 2003-08-27 Astex Technology Ltd Pharmaceutical compounds
EP1689719A1 (de) 2003-11-25 2006-08-16 Eli Lilly And Company 7-phenylisochinolin-5-sulfonylaminoderivate als inhibitoren von akt (proteinkinase b)

Also Published As

Publication number Publication date
PE20080338A1 (es) 2008-04-25
EA200970041A1 (ru) 2009-06-30
MX2008015904A (es) 2009-01-12
PL2035385T3 (pl) 2010-06-30
KR20090015978A (ko) 2009-02-12
KR101067551B1 (ko) 2011-09-27
US20090221633A1 (en) 2009-09-03
AU2007261120A1 (en) 2007-12-27
TW200812970A (en) 2008-03-16
EA015712B1 (ru) 2011-10-31
NO20090289L (no) 2009-01-19
EP2035385B1 (de) 2010-01-13
ECSP088992A (es) 2009-01-30
DOP2008000053A (es) 2009-01-15
PT2035385E (pt) 2010-03-01
AR061240A1 (es) 2008-08-13
JP2009541335A (ja) 2009-11-26
DK2035385T3 (da) 2010-03-22
ES2336630T3 (es) 2010-04-14
HRP20100147T1 (hr) 2010-04-30
TNSN08529A1 (en) 2010-04-14
SI2035385T1 (sl) 2010-05-31
DE602007004333D1 (de) 2010-03-04
MA30757B1 (fr) 2009-10-01
BRPI0713136A2 (pt) 2012-04-17
CA2652612A1 (en) 2007-12-27
CL2007001752A1 (es) 2008-01-18
WO2007149730A3 (en) 2008-04-24
US7998977B2 (en) 2011-08-16
WO2007149730A2 (en) 2007-12-27
EP2035385A2 (de) 2009-03-18
IL195005A0 (en) 2009-08-03

Similar Documents

Publication Publication Date Title
ATE455102T1 (de) Inhibitoren von akt (proteinkinase b)
CY2019009I2 (el) Αναστολεις πρωτεϊνικων κινασων
ATE479434T1 (de) Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine
CY2017012I2 (el) Αναστολεις κινασης τυροσινης bruton
EP2040546A4 (de) Tyrosinkinasehemmer
EP1807077A4 (de) Inhibitoren von c-fms-kinase
BRPI0910668A2 (pt) inibidores de proteína quinases
CR10755A (es) Compounds and compositions as protein kinase inhibitors
BRPI0717317A2 (pt) Modularoes da proteína cinase triazalopiridazina
BRPI0816064A2 (pt) Inibidores da atividade de proteína tirosina cinase.
EP1951684A4 (de) Biarylmetapyrimidinkinaseinhibitoren
DE602007014374D1 (de) Ä4,5'ü-bipyrimidinyl-6,4'-diaminderivate als proteinkinase-hemmer
DK1881976T3 (da) Substituerede amidderivater som proteinkinaseinhibitorer
EP1968950A4 (de) Pyrimidinkinaseinhibitoren
ATE518860T1 (de) Pyrroloä2,3-büpyridinderivate als proteinkinaseinhibitoren
DOP2007000082A (es) Inhibidores de quinasas de puntos de control
ATE493403T1 (de) Kinaseinhibitoren
ATE433449T1 (de) Kinaseinhibitoren
ATE520664T1 (de) Tyrosinkinase-hemmer
NO20084739L (no) Substituerte 3-cyanopyridiner som protein kinase inhibitorer
BRPI0719883A2 (pt) Inibidores de quinase
ZA200809545B (en) Inhibitors of Akt (protein kinase B)
EP1954717A4 (de) Peptid-hemmer von abl-kinase
ZA200902826B (en) IKK-B Serine-Threonine protein kinase inhibitors
LTC2379528I2 (lt) Baltymų kinazės slopikliai

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2035385

Country of ref document: EP